Common Questions About the Weight Loss Protocol

This article applies specifically to the Weight Loss treatment plan.

Requirements may differ for other Maximus programs.

The protocol uses GLP-1 and GLP-1 + GIP medications to help regulate appetite, improve fullness cues, and support metabolic health.

Results vary and are influenced by factors such as sleep, nutrition, activity, and overall health. Your clinician may request labs to confirm safety and eligibility.

Some individuals notice changes in appetite or portion sizes within the first few weeks. Others experience more gradual progress.

Your clinician evaluates progress over time using symptom trends and, when appropriate, lab results.

Possibly. Switching depends on your medical history, prior treatment, symptoms, and safety considerations.

Your clinician will determine whether a transition is appropriate.

The Starter Pack is designed for individuals new to GLP-1 treatment who want a structured introduction to the protocol.

Eligibility is determined based on your health history and clinician review.

If applicable, it may include introductory supplies or support materials based on your treatment plan.

For plan-specific details, a member of the team can help clarify what’s included.

Your clinician determines your starting dose based on:

Previous use does not automatically qualify you for a higher starting dose.

Starting at a lower dose helps:

Dose adjustments are made by your clinician based on your response.

Possibly. Your clinician will evaluate your response, symptoms, and safety considerations before recommending a change.

GLP-1 medications are well-studied and commonly used.

Some individuals experience digestive side effects such as nausea, diarrhea, or constipation. Your clinician determines whether treatment is appropriate for you.

Mild digestive symptoms are common, especially early in treatment.

If symptoms persist or worsen, message your clinician. Seek urgent care for severe symptoms.

Digestive symptoms are common early on.

If symptoms interfere with daily life or do not improve, message your clinician. Do not adjust your dose without guidance.

Healthy habits support progress, but approaches vary by individual.

Many people naturally adjust eating patterns as appetite changes. The Help Center does not provide individualized diet or exercise plans.

Medication supports appetite and metabolic signals, but:

all influence results.

Progress varies. Your clinician will review:

to determine next steps.

Duration varies based on:

Your clinician evaluates this over time.

Your clinician considers:

before making any adjustments.

Message your clinician for guidance.

Do not double up doses unless instructed.

Alcohol may affect digestion, appetite, sleep, and energy.

If you choose to drink, moderation is generally advisable. For individual concerns, message your clinician.

Weight patterns vary.

Long-term outcomes depend on:

Your clinician can discuss long-term planning with you.

Medications are fulfilled through licensed pharmacies.

Pharmacy partners source semaglutide and tirzepatide to match the active pharmaceutical ingredients used in clinical studies.

You can upload recent lab results through your patient portal.

Your clinician will determine whether they meet the requirements for your protocol.

If your shipment appears delayed, a member of the team can help review the status and coordinate next steps.

If you have questions about your symptoms, experience, or progress, message your clinician through your Maximus patient portal.